FADS2 and metabolic dysfunction-associated steatohepatitis: Changes in lipid composition in NASH resulted of the additional effect of increase in de novo short-chain fatty acids synthesis and in FADS2 and SCD1 activities associated to a decrease in ELOVL6 and FADS1 activities.